IP Library Granted Patent US 12,426,945
Granted Patent B2
US 12,426,945 · App. 16/995,921 · Granted Sep 30, 2025

Catheter with thin-film electrodes on expandable mechanical structure

Inventors: Shubhayu Basu (Anaheim, CA); Dustin R. Tobey (San Dimas, CA); Pieter E. Van Niekerk (Monrovia, CA); Cesar Fuentes-Ortega (Pasadena, CA)
Assignee: Biosense Webster (Israel) Ltd.
A61B18/1492A61B5/287A61B5/6852A61B5/6853A61B2017/00199A61B2017/00862A61B2017/00867A61B2018/00077A61B2018/00214A61B2018/00351A61B2018/00577A61B2018/00613A61B2018/00797A61B2018/00815A61B2018/00821A61B2018/1467A61B2034/2048A61B2034/2051A61B2034/2055A61B2034/2063A61B2218/002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,426,945
App. No.
16/995,921
Filed
Aug 18, 2020
Granted
Sep 30, 2025
Kind
B2
Art Unit
3794
USPC
606/41
Abstract

An apparatus includes a catheter and an end effector. At least a portion of the catheter is sized and configured to fit within a lumen of a cardiovascular system. The end effector is positioned at a distal end of the catheter. The end effector includes a panel, a plurality of mapping electrodes positioned on a first surface of the panel, and a plurality of ablation electrodes positioned on the first surface of the panel. The mapping electrodes are configured to sense electrical potentials in tissue contacting the mapping electrodes. The ablation electrodes are operable to ablate tissue contacting the ablation electrodes.

Claims (26)

1. An apparatus comprising:

(a) a catheter having a central longitudinal axis, at least a portion of the catheter being sized and configured to fit within a lumen of a cardiovascular system; and

(b) an end effector positioned at a distal end of the catheter, the end effector comprising:

(i) a panel comprising a proximal tab portion, a distally extending portion, and a transition portion between the proximal tab portion and the distally extending portion, the transition portion being narrower than both the proximal tab portion and the distally extending portion, the distally extending portion being biased to assume an expanded configuration, the proximal tab portion comprising two laterally extending ears that are rolled to form a generally cylindrical proximal tab that is fixedly secured along an inner perimeter of a distal end of the catheter such that when in the expanded configuration the distally extending portion extends laterally offset from the central longitudinal axis of the catheter, the proximal tab defining an opening configured to pass fluid from the catheter to an area outside of the distal end of the catheter and proximal of the distally extending portion of the panel,

(ii) a plurality of mapping electrodes positioned on a first surface of the distally extending portion of the panel, the mapping electrodes being configured to sense electrical potentials in tissue contacting the mapping electrodes, and

(iii) a plurality of ablation electrodes positioned on the first surface of the distally extending portion of the panel, the ablation electrodes being operable to ablate tissue contacting the ablation electrodes.

2. The apparatus of claim 1 , the distally extending portion of the panel being biased to assume a generally flat shape in the expanded configuration.

3. The apparatus of claim 1 , the distally extending portion of the panel having a generally rectangular shape.

4. The apparatus of claim 1 , the catheter including an outer sheath, the outer sheath and end effector being configured to transition between a first state and a second state, the end effector being contained within the outer sheath in the first state, the end effector being exposed relative to the outer sheath in the second state.

5. The apparatus of claim 4 , the panel comprising a camming feature configured to cooperate with a distal end of the outer sheath to thereby urge the panel from the expanded configuration to a non-expanded configuration in response to the outer sheath and end effector transitioning from the second state to the first state.

6. The apparatus of claim 1 , the distally extending portion of the panel being resiliently biased to assume the expanded configuration.

7. The apparatus of claim 6 , the distally extending portion of the panel including a resilient material biasing the distally extending portion of the panel to assume the expanded configuration.

8. The apparatus of claim 7 , the distally extending portion of the panel including a plurality of layers, at least one of the layers comprising the resilient material.

9. The apparatus of claim 8 , the plurality of layers further including a non-conductive layer, at least one of the mapping electrodes and at least one of the ablation electrodes being positioned on a first side of the non-conductive layer, the resilient material being positioned on a second side of the non-conductive layer.

10. The apparatus of claim 1 , the end effector further comprising an inflatable member, the panel being secured to the inflatable member, the inflatable member being configured to bias the panel to assume the expanded configuration.

11. The apparatus of claim 10 , the inflatable member being configured to define a cylindraceous shape in an inflated state.

12. The apparatus of claim 10 , the inflatable member being configured to define a generally flat rectangular shape in an inflated state.

13. The apparatus of claim 1 , the end effector further comprising one or more reference electrodes positioned on a second surface of the distally extending portion of the panel, the second surface being opposite to the first surface.

14. The apparatus of claim 13 , the second surface of the distally extending portion of the panel including a feature to prevent the one or more reference electrodes from contacting tissue adjacent to the second surface.

15. The apparatus of claim 14 , the feature to prevent the one or more reference electrodes from contacting tissue comprising:

a protruding wall generally surrounding a respective reference electrode and protruding from the second surface; or a recess in the second surface in which the respective reference electrode sits.

16. The apparatus of claim 1 , the mapping electrodes being arranged in a first matrix of rows and columns along the first surface, the ablation electrodes being arranged in a second matrix of rows and columns along the first surface, the second matrix being offset from the first matrix.

17. The apparatus of claim 1 , the end effector further comprising a plurality of temperature sensors.

18. The apparatus of claim 1 , the distally extending portion of the panel further comprising a plurality of openings through the panel.

19. The apparatus of claim 1 , the distally extending portion of the panel comprising a plurality of cuts through the first surface and an opposing second surface of the distally extending portion of the panel such that the plurality of cuts separate the distally extending portion of the panel into a plurality of strips, the strips being movable relative to each other at the cuts.

20. The apparatus of claim 19 , the strips of the plurality of strips being configured to fan out from each other or separate from each other along multiple dimensions.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2020
From: BASU, SHUBHAYU; TOBEY, DUSTIN R.; VAN NIEKERK, PIETER E.; FUENTES-ORTEGA, CESAR
To: BIOSENSE WEBSTER (ISRAEL) LTD.
Reel/Frame 053757/0158 →
Continuity (2)
Provisional Application 62901824 · Sep 18, 2019
Related Publication 20210077183A1 · Mar 18, 2021
References Cited (57)
US 5404638A · Imran · 1995 [cited by applicant]
US 5738096A · Ben-Haim · 1998 [cited by applicant]
US 5827273A · Edwards · 1998 [cited by applicant]
US 5846196A · Siekmeyer · 1998 [cited by examiner]
US 6315776B1 · Edwards et al. · 2001 [cited by applicant]
US 6325972B1 · Jacobs et al. · 2001 [cited by applicant]
US 6365102B1 · Wu et al. · 2002 [cited by applicant]
US 6447719B1 · Agamohamadi et al. · 2002 [cited by applicant]
US 6852277B2 · Platt, Jr. et al. · 2005 [cited by applicant]
US 6852279B2 · Williams et al. · 2005 [cited by applicant]
US 6939519B2 · Agamohamadi et al. · 2005 [cited by applicant]
US 8295902B2 · Salahieh et al. · 2012 [cited by applicant]
US 8956353B2 · Govari et al. · 2015 [cited by applicant]
US 9131836B2 · Huszar et al. · 2015 [cited by applicant]
US 9186060B2 · De Graff et al. · 2015 [cited by applicant]
US 9314299B2 · Fang · 2016 [cited by applicant]
US 9370311B2 · Stewart et al. · 2016 [cited by applicant]
US 9480416B2 · Govari et al. · 2016 [cited by applicant]
US 9801585B2 · Shah et al. · 2017 [cited by applicant]
US 9848795B2 · Marecki et al. · 2017 [cited by applicant]
US 9907480B2 · Basu et al. · 2018 [cited by applicant]
US 10061198B2 · Lima De Miranda · 2018 [cited by applicant]
US 10105179B2 · Harlev et al. · 2018 [cited by applicant]
US 10130442B2 · Dor et al. · 2018 [cited by applicant]
US 10561753B2 · Thompson et al. · 2020 [cited by applicant]
US 10575743B2 · Basu et al. · 2020 [cited by applicant]
US 10660700B2 · Beeckler et al. · 2020 [cited by applicant]
US 10702177B2 · Aujla · 2020 [cited by applicant]
US 10743932B2 · Gallardo et al. · 2020 [cited by applicant]
US 10898139B2 · Guta et al. · 2021 [cited by applicant]
US 11026746B2 · Townley et al. · 2021 [cited by applicant]
US 20150351652A1 · Marecki · 2015 [cited by examiner]
US 20170071543A1 · Basu et al. · 2017 [cited by applicant]
US 20180071017A1 · Bar-Tal · 2018 [cited by examiner]
US 20180133460A1 · Townley · 2018 [cited by examiner]
US 20180325587A1 · Buelna · 2018 [cited by applicant]
US 20190159835A1 · Ibrahim · 2019 [cited by applicant]
CA 2471106A1 · 1995 [cited by applicant]
CN 104470454B · 2018 [cited by applicant]
DE 102017130152B3 · 2019 [cited by applicant]
WO 1999008614A1 · 1999 [cited by applicant]
WO WO00066021A1 · 2000 [cited by applicant]
WO WO2011143468A2 · 2011 [cited by applicant]
WO WO2015117908A1 · 2015 [cited by applicant]
WO WO2016123390A1 · 2016 [cited by applicant]
WO WO2019036653A2 · 2019 [cited by applicant]
WO 2021053483A1 · 2021 [cited by applicant]
U.S. Appl. No. 62/819,738, filed Mar. 18, 2019, by Basu et al., entitled: “Electrode Configurations for Diagnosis of Arrhythmias.” [cited by applicant]
U.S. Appl. No. 62/901,824, filed Sep. 18, 2019, by Basu et al., entitled: “Catheter With Thin-Film Electrodes on Expandable Mechanical Structure.” [cited by applicant]
International Search Report and Written Opinion dated Apr. 16, 2021 for Application No. PCT/IB2020/058355, 16 pgs. [cited by applicant]
European Communication dated Nov. 14, 2023, for Application No. 20785601.4, 6 pages. [cited by applicant]
Japanese Notification of Reasons for Refusal dated Mar. 5, 2024, for Application No. 2022-517429, 6 pages. [cited by applicant]
Chinese Office Action, The First Office Action and First Search, dated Aug. 15, 2024 for Application No. CN 202080065607.1, 11 pgs. [cited by applicant]
Chinese Office Action, The Second Office Action, dated Dec. 5, 2024 for Application No. CN 202080065607.1, 4 pgs. [cited by applicant]
European Search Report and Written Opinion dated Feb. 13, 2025 for Application No. EP 25151816.3, 11 pgs. [cited by applicant]
Invitation to Pay Additional Fees and, Where Applicable, Protest Fee dated Jan. 12, 2021 for International Application No. PCT/IB2020/058355, 10 pgs. [cited by applicant]
U.S. Food & Drug Administration, “FDA-Cleared Sterilants and High Level Disinfectants with General Claims for Processing Reusable Medical and Dental Devices—Mar. 2015,” downloaded Jun. 21, 2019 from https://www.fda.gov/… [cited by applicant]